4:31 PM ET
8-K
Executive Compensation
Cingulate Executive Compensation
Cingulate Inc.'s subsidiary, Cingulate Therapeutics LLC, entered into an amendment to the employment agreement of Matthew N. Brams, the company's Executive Vice President and Chief Medical Officer. The amendment extends the trial period for Mr. Brams' full-time employment from September 30, 2026, to December 31, 2026.
- Term
- through Dec 2026